Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure. Yoon S, Shin SJ, Kim HC, Kim YS, et al. Eur J Cancer 2022;174:81-89.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yoon S, Shin SJ, Kim HC, Kim YS, et al. Enfortumab vedotin-related pneumonitis is more common than expected and could lead to acute respiratory failure. Eur J Cancer 2022;174:81-89.
PMID: 35985251